CCR
C-C chemokine receptors (CCRs) are a group of GPCRs that respond to chemokines, which are signaling molecules that guide the migration of immune cells to sites of inflammation or infection. CCRs play crucial roles in immune responses, inflammation, and the development of various diseases, including autoimmune disorders and cancer. Modulation of CCR activity is being explored as a therapeutic strategy for conditions such as rheumatoid arthritis, multiple sclerosis, and HIV infection. At CymitQuimica, we provide a range of high-quality CCR modulators to support your research in immunology, inflammation, and therapeutic development.
Read more
CCR4 antagonist 3-1
CAS:1957-01-3
CCR4 antagonist 3-1 is a weak inhibitor of [125I]TARC binding and CEM cell migration, with …
Formula:
C14H12N2S
Purity:
99.53%
Color and Shape:
Liquid
Molecular weight:
240.32
Ref: TM-T60336
| 1mg | 90.00 € | ||
| 5mg | 212.00 € | ||
| 10mg | 346.00 € | ||
| 25mg | 677.00 € | ||
| 50mg | 1,050.00 € | ||
| 100mg | 1,420.00 € | ||
| 500mg | 2,756.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
C-021 dihydrochloride
CAS:1784252-84-1
C-021 dihydrochloride is a potent CCR4 antagonist. It potently inhibits functional chemotaxis in human and …
Formula:
C27H43Cl2N5O2
Purity:
98.51%
Color and Shape:
Solid
Molecular weight:
540.57
Ref: TM-T10639
| 1mg | 52.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 152.00 € | ||
| 25mg | 246.00 € | ||
| 50mg | 370.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
CCR1 antagonist 9
CAS:1220026-26-5
CCR1 antagonist 9 is an effective and selective CCR1 antagonist (IC50: 6.8 nM in calcium …
Formula:
C20H16FN5O3S
Color and Shape:
Solid
Molecular weight:
425.44
Ref: TM-T10710
| 5mg | 243.00 € | ||
| 25mg | 792.00 € | ||
| 50mg | 1,039.00 € | ||
| 100mg | 1,507.00 € | ||
| 1mL*10mM (DMSO) | 295.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
BMS-817399
CAS:1202400-18-7
BMS-817399: oral CCR1 antagonist with binding and chemotaxis inhibition IC50s, potential for rheumatoid arthritis research.
Formula:
C23H36ClN3O4
Purity:
99.05%
Color and Shape:
Solid
Molecular weight:
454
Ref: TM-T26861
| 1mg | 155.00 € | ||
| 5mg | 325.00 € | ||
| 10mg | 492.00 € | ||
| 25mg | 782.00 € | ||
| 50mg | 1,052.00 € | ||
| 100mg | 1,417.00 € | ||
| 1mL*10mM (DMSO) | 362.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
CCR1 antagonist 7
CAS:2446154-74-9
CCR1 antagonist 7 (compound 16r) is an antagonist of chemokine receptor 1 (CCR1) with an …
Formula:
C21H24ClN5O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
461.96
Ref: TM-T10709
| 25mg | 1,410.00 € | ||
| 50mg | 1,852.00 € | ||
| 100mg | 2,338.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
GW 766994
CAS:408303-43-5
GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist. It has the potential …
Formula:
C21H24Cl2N4O3
Color and Shape:
Solid
Molecular weight:
451.35
Ref: TM-T11521
| 25mg | 1,113.00 € | ||
| 50mg | 1,460.00 € | ||
| 100mg | 2,340.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
SB 328437
CAS:247580-43-4
SB 328437 ((S)-methyl 2-(1-naphthamido)-3-(4-nitrophenyl)propanoate) is an effective and selective antagonist of CCR3 (IC50 = 4.5 …
Formula:
C21H18N2O5
Purity:
99.11%
Color and Shape:
Solid
Molecular weight:
378.38
Ref: TM-T23321
| 1mg | 48.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 151.00 € | ||
| 25mg | 294.00 € | ||
| 50mg | 482.00 € | ||
| 100mg | 701.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
YM022
CAS:145084-28-2
YM022 is a highly effective and selective gastrin/cholecystokinin (CCK)-B receptor antagonist.
Formula:
C32H28N4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
516.59
Ref: TM-T17274
| 10mg | 636.00 € | ||
| 50mg | 2,599.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
CCR2 antagonist 5
CAS:1228650-83-6
JNJ-41443532: oral hCCR2 antagonist, IC50=37 nM, anti-chemotaxis, treats inflammation & diabetes.
Formula:
C22H25F3N4O3S
Purity:
98.79%
Color and Shape:
Solid
Molecular weight:
482.52
Ref: TM-T27682
| 1mg | 97.00 € | ||
| 5mg | 232.00 € | ||
| 10mg | 349.00 € | ||
| 25mg | 621.00 € | ||
| 50mg | 885.00 € | ||
| 100mg | 1,203.00 € | ||
| 200mg | 1,621.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
AZD2423
CAS:1229603-37-5
AZD2423 is a potent, selective, orally bioavailable, and non-competitive CCR2 chemokine receptor negative allosteric modulator …
Formula:
C20H29ClFN5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
425.93
Ref: TM-T14373
| 25mg | 1,827.00 € | ||
| 50mg | 2,412.00 € | ||
| 100mg | 3,178.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
CCR2 antagonist 4
CAS:226226-39-7
CCR2 antagonist 4 (Teijin compound 1) is a potent and specific antagonist of CCR2(IC50s of …
Formula:
C21H21ClF3N3O2
Purity:
99.63%
Color and Shape:
Solid
Molecular weight:
439.86
Ref: TM-T13114
| 1mg | 52.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 184.00 € | ||
| 25mg | 322.00 € | ||
| 50mg | 478.00 € | ||
| 100mg | 680.00 € | ||
| 1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
PF-04634817
CAS:1228111-63-4
PF-0463481: safe, well-tolerated, dual CCR2/CCR5 antagonist for diabetic nephropathy; similar human/rodent CCR2 potency, less rodent …
Formula:
C25H36F3N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
511.58
Ref: TM-T12419L
| 25mg | 1,688.00 € | ||
| 50mg | 2,225.00 € | ||
| 100mg | 2,897.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
SB-649701
CAS:935262-95-6
SB-649701 is a potent antagonist of the human CCR8 receptor, exhibiting a pIC50 value of …
Formula:
C27H28N4O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
456.54
Ref: TM-T79095
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
IPG7236
CAS:2756350-91-9
IPG7236, a selective CCR8 antagonist, demonstrates notable tumor suppression in a mouse xenograft model of …
Formula:
C23H31N3O3S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
429.58
Ref: TM-T79096
| 25mg | 1,549.00 € | ||
| 50mg | 2,038.00 € | ||
| 100mg | 2,617.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
CMPD167
CAS:313994-79-5
CMPD167 (MRK-1) is a potent, orally active inhibitor of CCR5 with significant in vitro antiviral …
Formula:
C35H47FN4O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
574.77
Ref: TM-T82702
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
CCR3 antagonist 1
CAS:879399-82-3
CCR3 antagonist 1 is a potent CCR3 antagonist, used for the research of inflammatory and …
Formula:
C19H21Cl2N3O4S2
Purity:
99.85%
Color and Shape:
Solid
Molecular weight:
490.42
Ref: TM-T10156
| 1mg | 90.00 € | ||
| 5mg | 185.00 € | ||
| 10mg | 300.00 € | ||
| 25mg | 479.00 € | ||
| 50mg | 642.00 € | ||
| 100mg | 866.00 € | ||
| 1mL*10mM (DMSO) | 222.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
INCB3344
CAS:1262238-11-8
INCB3344 is an effective, specific and orally bioavailable CCR2 antagonist with IC50 values of 9.5 …
Formula:
C29H34F3N3O6
Purity:
98.00% - 98.2%
Color and Shape:
Solid
Molecular weight:
577.59
Ref: TM-TQ0103
| 1mg | 69.00 € | ||
| 5mg | 150.00 € | ||
| 10mg | 237.00 € | ||
| 25mg | 402.00 € | ||
| 50mg | 596.00 € | ||
| 100mg | 852.00 € | ||
| 1mL*10mM (DMSO) | 187.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
CCR1 antagonist 8
CAS:1295298-26-8
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM …
Formula:
C22H18FN5O3S
Color and Shape:
Solid
Molecular weight:
451.47
Ref: TM-T14899
| 25mg | 1,002.00 € | ||
| 50mg | 1,320.00 € | ||
| 100mg | 1,994.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
CCR2 antagonist 1
CAS:1683534-96-4
CCR2 antagonist 1 is a high-affinity and long-residence-time antagonist of CCR2 (Ki: 2.4 nM).
Formula:
C28H32BrF3N2O
Color and Shape:
Solid
Molecular weight:
549.47
Ref: TM-T10711
| 25mg | 2,059.00 € | ||
| 50mg | 2,705.00 € | ||
| 100mg | 4,109.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
MLN-3897
CAS:1010731-97-1
MLN-3897 is an oral CCR1 antagonist, Ki 2.3 nM, blocks 125I-MIP-1α binding, and inhibits Akt …
Formula:
C30H31ClN2O4
Purity:
98.62%
Color and Shape:
Solid
Molecular weight:
519.03
Ref: TM-T28072
| 25mg | 1,234.00 € | ||
| 50mg | 1,605.00 € | ||
| 100mg | 2,408.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
